Positive Patient Stories™

Paratek Pharmaceuticals News

Webcast ImageWebcast
Fourth Quarter and Fiscal Year 2018 Earnings Call  (Replay)
02/27/19 at 4:30 p.m. ET
Fourth Quarter and Fiscal Year 2018 Earnings Call
Wednesday, February 27, 2019 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
8th Annual SVB Leerink Global Healthcare Conference (Replay)
02/28/19 at 1:00 p.m. ET
8th Annual SVB Leerink Global Healthcare Conference
Thursday, February 28, 2019 1:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Paratek Pharmaceuticals Presentation at the Cowen and Company 39th Annual Health Care Conference (Replay)
03/13/19 at 10:00 a.m. ET
Paratek Pharmaceuticals Presentation at the Cowen and Company 39th Annual Health Care Conference
Wednesday, March 13, 2019 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015
DateTitle  
12/03/15Paratek Expands Leadership Team 
11/12/15Paratek Pharmaceuticals, Inc. Reports Third Quarter 2015 Financial and Operating Results 
11/09/15Paratek Initiates Omadacycline Phase 3 Clinical Study in Community Acquired Bacterial Pneumonia (CABP) 
11/05/15Paratek Pharmaceuticals to Report Third Quarter 2015 Financial Results on November 12, 2015 
11/04/15Paratek Receives FDA Fast Track Designation for Omadacycline 
10/01/15Paratek Expands Leadership Team With Two New Hires 
09/02/15Paratek Pharmaceuticals, Inc. Announces Participation in Ladenburg Thalmann 2015 Healthcare Conference 
08/05/15Paratek Pharmaceuticals, Inc. Reports Second Quarter 2015 Financial and Operating Results 
08/03/15Paratek Pharmaceuticals to Present Data at ICAAC 2015 
07/28/15Paratek Pharmaceuticals to Report Second Quarter 2015 Financial Results on August 5, 2015 
07/24/15Paratek Announces Termination of Tax Benefit Preservation Plan 
07/22/15Timothy Franson M.D. Joins Paratek's Board of Directors 
07/21/15Paratek Pharmaceuticals Opens New Corporate Headquarters in Boston 
07/01/15Paratek Hires William Haskel as Senior Vice President, General Counsel and Corporate Secretary 
06/23/15Paratek Doses First Patient in Phase 3 Clinical Trial of Omadacycline in Acute Bacterial Skin and Skin Structure Infections 
06/22/15Paratek Set to Join Russell 3000(R) and Russell Global Indexes 
06/17/15Paratek Pharmaceuticals to Present at Upcoming Banking Conferences 
06/11/15Paratek Pharmaceuticals Opens Philadelphia Office 
06/03/15Paratek Pharmaceuticals Strengthens Senior Leadership Team 
05/15/15Paratek Pharmaceuticals, Inc. Reports First Quarter 2015 Financial and Operating Results 
05/05/15Paratek Announces Closing of Common Stock Offering 
04/29/15Paratek Announces Pricing of Public Offering of 2,860,000 Shares of Common Stock 
04/27/15Paratek Announces Proposed Public Offering of Common Stock 
04/02/15Paratek Pharmaceuticals, Inc. Reports Full Year 2014 Financial and Operating Results 
03/12/15Paratek Pharmaceuticals to Present at Two Upcoming Investor Conferences 
02/23/15Paratek Pharmaceuticals to Present at the Cowen Healthcare Conference 
02/10/15Paratek Pharmaceuticals Adopts Inducement Equity Incentive Plan Under NASDAQ Listing Rule 5635(c)(4) 
02/10/15Paratek Pharmaceuticals to Present at the Leerink Global Healthcare Conference 
01/06/15Paratek to Receive $4 Million Payment From Actavis With Initiation of Phase 3 Trial of Sarecycline 

Talk with the Paratek Team

Send us an inquiry by submitting a form directly on the site or give us a call.